Effect of Surgical Site Infections on Patient Reported Cosmetic Outcomes in Dermatologic Surgery
1 other identifier
observational
114
1 country
1
Brief Summary
This study involves surveying two matched groups of patients that underwent dermatologic surgery at our department. One group had a documented surgical site infection and the other didn't. All patients will be asked to complete a questionnaire in which they assess the physical appearance of their scars and its psychosocial impact. Results will be compared between the groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 3, 2021
CompletedFirst Posted
Study publicly available on registry
February 9, 2021
CompletedStudy Start
First participant enrolled
February 24, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 17, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 17, 2021
CompletedMay 18, 2021
May 1, 2021
3 months
February 3, 2021
May 17, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Comparing mean values of SCAR-Q scores in both groups
Scar-Q (http://qportfolio.org/scar-q/) is a patient reported outcome instrument in which scars will be assessed in terms of scar appearance and psychosocial impact. Scores will range from 0 (worst) to 100 (best). Scores will be compared between the two groups using either parametric or non-parametric tests depending on the distribution of the results.
3 months
Secondary Outcomes (1)
Association between patient characteristics and SCAR-Q scores
3 months
Study Arms (2)
Surgical site infections
Normal would healing
Interventions
Eligibility Criteria
All included patients had a surgical procedure performed at our department. One group had documented surgical site infections and the other didn't.
You may qualify if:
- Patient above 18 years of age that underwent a dermatosurgical procedure at our department between march 2017 and march 2020.
You may not qualify if:
- Patients assessed as not suitable for telephone survey due to hearing disabilities or cognitive impairment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Region Skanelead
Study Sites (1)
Department of dermatology, Skåne university hospital
Lund, 22185, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator, M.D, Ph.D
Study Record Dates
First Submitted
February 3, 2021
First Posted
February 9, 2021
Study Start
February 24, 2021
Primary Completion
May 17, 2021
Study Completion
May 17, 2021
Last Updated
May 18, 2021
Record last verified: 2021-05